Home/Filings/4/0001610717-24-000041
4//SEC Filing

Ruiz Briseno Andres 4

Accession 0001610717-24-000041

CIK 0001676725other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 7:12 PM ET

Size

5.3 KB

Accession

0001610717-24-000041

Insider Transaction Report

Form 4
Period: 2024-01-22
Transactions
  • Sale

    Common Stock

    2024-01-22$42.03/sh2,000$84,05026,531 total
Footnotes (2)
  • [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023.
  • [F2]This transaction was executed in multiple trades in prices ranging from $42.00 to $42.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001983118

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 7:12 PM ET
Size
5.3 KB